Vaxart Inc Performance
| VXRTDelisted Stock | USD 0.35 0.05 16.67% |
On a scale of 0 to 100, Vaxart holds a performance score of 3. The entity has a beta of 2.73, which indicates a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Vaxart will likely underperform. Please check Vaxart's maximum drawdown, skewness, as well as the relationship between the Skewness and day typical price , to make a quick decision on whether Vaxart's existing price patterns will revert.
Risk-Adjusted Performance
Insignificant
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Vaxart Inc are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unfluctuating basic indicators, Vaxart unveiled solid returns over the last few months and may actually be approaching a breakup point. ...more
| Begin Period Cash Flow | 34.8 M |
Vaxart |
Vaxart Relative Risk vs. Return Landscape
If you would invest 34.00 in Vaxart Inc on April 22, 2025 and sell it today you would earn a total of 1.00 from holding Vaxart Inc or generate 2.94% return on investment over 90 days. Vaxart Inc is currently generating 0.4276% in daily expected returns and assumes 8.942% risk (volatility on return distribution) over the 90 days horizon. In different words, 80% of stocks are less volatile than Vaxart, and 92% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Vaxart Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Vaxart's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Vaxart Inc, and traders can use it to determine the average amount a Vaxart's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0478
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | VXRT | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 8.94 actual daily | 80 80% of assets are less volatile |
Expected Return
| 0.43 actual daily | 8 92% of assets have higher returns |
Risk-Adjusted Return
| 0.05 actual daily | 3 97% of assets perform better |
Based on monthly moving average Vaxart is performing at about 3% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Vaxart by adding it to a well-diversified portfolio.
Vaxart Fundamentals Growth
Vaxart Stock prices reflect investors' perceptions of the future prospects and financial health of Vaxart, and Vaxart fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Vaxart Stock performance.
| Return On Equity | -1.15 | ||||
| Return On Asset | -0.29 | ||||
| Profit Margin | (1.23) % | ||||
| Operating Margin | (0.72) % | ||||
| Current Valuation | 43.36 M | ||||
| Shares Outstanding | 228.22 M | ||||
| Price To Book | 1.50 X | ||||
| Price To Sales | 1.54 X | ||||
| Revenue | 28.7 M | ||||
| EBITDA | (54.87 M) | ||||
| Cash And Equivalents | 129.55 M | ||||
| Cash Per Share | 1.02 X | ||||
| Total Debt | 17.53 M | ||||
| Debt To Equity | 0.09 % | ||||
| Book Value Per Share | 0.20 X | ||||
| Cash Flow From Operations | (44.76 M) | ||||
| Earnings Per Share | (0.26) X | ||||
| Total Asset | 166.39 M | ||||
| Retained Earnings | (476.52 M) | ||||
About Vaxart Performance
Assessing Vaxart's fundamental ratios provides investors with valuable insights into Vaxart's financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Vaxart is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
Vaxart, Inc., a clinical-stage biotechnology company, engages in the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company is headquartered in South San Francisco, California. Vaxart operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 110 people.Things to note about Vaxart Inc performance evaluation
Checking the ongoing alerts about Vaxart for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Vaxart Inc help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Vaxart Inc is not yet fully synchronised with the market data | |
| Vaxart Inc had very high historical volatility over the last 90 days | |
| Vaxart Inc has some characteristics of a very speculative penny stock | |
| Vaxart Inc has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 28.7 M. Net Loss for the year was (66.95 M) with loss before overhead, payroll, taxes, and interest of (38.55 M). | |
| Vaxart Inc currently holds about 129.55 M in cash with (44.76 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.02, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Latest headline from gurufocus.com: OTC Markets Group Welcomes Vaxart, Inc. to OTCQX |
- Analyzing Vaxart's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Vaxart's stock is overvalued or undervalued compared to its peers.
- Examining Vaxart's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Vaxart's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Vaxart's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Vaxart's stock. These opinions can provide insight into Vaxart's potential for growth and whether the stock is currently undervalued or overvalued.
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.
Other Consideration for investing in Vaxart Stock
If you are still planning to invest in Vaxart Inc check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Vaxart's history and understand the potential risks before investing.
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum |